Bitcoin: Has it Hit an Inflection Point?

Bitcoin could be at an inflection point, whether favourable or unfavourable, in 2021. While waiting for developments in the crypto space, Hut 8 Mining stock and HIVE Blockchain Technologies stock are the next-best alternatives to digital assets.

| More on:

Crypto bulls are a worried lot in 2021, as Bitcoin underperforms versus stocks once more. Some market observers, however, say July is historically not a good time for crypto investors. Despite the recent collapse, it seems cryptos have reached a critical moment, if not an inflection point. Is a significant change, positive or negative, coming to the space?

Potential inflection points

Besides its volatile nature, actions by governments, like banning crypto trading and mining or introducing regulatory changes, could lead to a negative inflection point. Carsten Murawski, a finance professor at the University of Melbourne in Australia, says authorities want to control digital currencies.

Likewise, central banks view cryptocurrencies as threats to financial stability. He added they don’t want parallel currencies floating around. For Tom Jessop of Fidelity, the pandemic was a catalyst for broader acceptance or adoption. He said there’s an acceleration of institutions studying and evaluating the crypto universe. They could move to operationalize the digital assets soon.

Since we’re still in the early stages, uncertainties persist, making BTC shaky and very risky. The alternative investments, for now, are crypto, blockchain, or technology stocks. While it could mirror Bitcoin’s fluctuations, TSX assets are safer.

Top Bitcoin miner

Hut 8 Mining (TSXV:HUT)(NASDAQ:HUT) is perhaps the top choice, because the company engages in Bitcoin mining. The crypto stock is also cross-listed on the U.S. stock exchange. At $6.04 per share, current investors are up 73% year to date, although the price has risen to as high as $11.09 in mid-March 2021.

The $860.77 company takes pride in being one of the oldest, largest, and innovative-focused digital asset mining pioneers in North America. Apart from Bitcoin mining, Hut 8’s executive team has deep experience in blockchain, software, investment banking, venture capital, and government.

Hut 8’s diversified mobile production platform is in Alberta (Medicine Hat and Drumheller), with secured low-cost power contracts. Business growth is visible, given the record level quarterly revenue of $32.5 million in Q1 2021 (quarter ended March 31, 2020), or 156% over Q1 2020.

Blockchain super growth wave

HIVE Blockchain Technologies (TSXV:HIVE) has an explosive start in 2021, like BTC. From $2.50 on January 4, 2021, the price soared 172% to $6.80 on February 19, 2021. Similar to real crypto, the rally did not sustain. As of July 9, 2021, HIVE trades at $3.11 per share.

The first-mover advantage belongs to HIVE. The $1.25 billion company is a pure-play blockchain investment. As a blockchain infrastructure company, its goal is to bridge blockchain and cryptocurrencies to traditional capital markets. Furthermore, HIVE has low working capital requirements. It can sell its mined coins strategically to maximize profit.

HIVE believes Ethereum, not BTC, will continue to be the backbone of this new financial ecosystem. Management expects to ride on the blockchain super growth wave through Ethereum. They want investors to know that this crypto has substantially more developers building on it than any other blockchain platform.

Gateway to the new technology world

Fidelity’s Jessop believes Bitcoin is the gateway to the new technology world, mainly due to more use cases. It could be a new operating system for financial services. You have a way to potentially move value around the planet more efficiently and more automated. There would be certain features that are not possible in a traditional framework.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »